Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Protein-altering germline mutations implicate novel genes related to lung cancer development
